title: Progress and prospects: zinc-finger nucleases as gene therapy agents.
abstract: Zinc-finger nucleases (ZFNs) are powerful tools for experimental gene manipulation. A number of recent papers have shown how this technology can be applied effectively to models of human gene therapy. Significant target genes and useful methods of ZFN delivery have been reported. Important strides have been made in minimizing toxic side effects observed with some ZFNs, which bodes well for their ultimate safety. New tools are available for the design and testing of ZFNs for new target genes. Applications of ZFNs to stem cells have been described, and genuine gene therapy trials appear to be on the immediate horizon.
authors.affiliation: Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112-5650, USA. dana@biochem.utah.edu
authors.forename: D
authors.initials: D
authors.lastname: Carroll
mesh_terms: D000818:Animals; D004720:Endonucleases / Q000235:genetics*; D005544:Forecasting; D005818:Genetic Engineering / Q000379:methods; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends; D005822:Genetic Vectors / Q000235:genetics*; D006801:Humans; D016335:Zinc Fingers / Q000235:genetics*
chemical_list: D004720:Endonucleases
references.citation: Nat Protoc. 2006;1(3):1637-52
references.pmid: 17406455
references.citation: Nat Biotechnol. 2007 Jul;25(7):778-85
references.pmid: 17603475
references.citation: Curr Gene Ther. 2006 Dec;6(6):633-45
references.pmid: 17168696
references.citation: Nat Biotechnol. 2007 Nov;25(11):1298-306
references.pmid: 17965707
references.citation: Nat Protoc. 2006;1(3):1329-41
references.pmid: 17406419
references.citation: Nat Biotechnol. 2007 Jul;25(7):786-93
references.pmid: 17603476
references.citation: Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W516-23
references.pmid: 16845061
references.citation: Mol Ther. 2008 Jul;16(7):1200-7
references.pmid: 18545224
references.citation: Mol Ther. 2006 Feb;13(2):438-46
references.pmid: 16169774
references.citation: Nat Biotechnol. 2008 Jun;26(6):695-701
references.pmid: 18500337
references.citation: Nat Biotechnol. 2008 Jul;26(7):808-16
references.pmid: 18587387
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16370-5
references.pmid: 17060623
references.citation: Nat Biotechnol. 2008 Jun;26(6):702-8
references.pmid: 18500334
references.citation: Genetics. 2006 Apr;172(4):2391-403
references.pmid: 16452139
references.citation: Mol Cell. 2008 Jul 25;31(2):294-301
references.pmid: 18657511
references.citation: Curr Gene Ther. 2007 Feb;7(1):49-66
references.pmid: 17305528
references.citation: Nat Methods. 2008 May;5(5):374-5
references.pmid: 18446154
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5809-14
references.pmid: 18359850
references.citation: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3055-60
references.pmid: 17360608
references.citation: Mol Ther. 2008 Apr;16(4):707-17
references.pmid: 18334988
references.citation: Nucleic Acids Res. 2008 Jul;36(12):3926-38
references.pmid: 18511461
references.citation: Mol Ther. 2008 Feb;16(2):352-358
references.pmid: 28178540